BP-180-specific IgG antibodies: A potential useful candidate for early diagnosis of Bullous pemphigoid during anti-PD-1/anti-PDL-1 of melanoma patients

Med Hypotheses. 2021 Dec:157:110703. doi: 10.1016/j.mehy.2021.110703. Epub 2021 Oct 9.

Authors

A Tsiakou¹, T Douvali², S Gregoriou³

Affiliations

¹ Andreas Syngros Hospital of Venereal & Dermatological Diseases, Athens, Greece. Electronic address: [email protected].
² Andreas Syngros Hospital of Venereal & Dermatological Diseases, Athens, Greece.
³ National and Kapodistrian University of Athens Faculty of Medicine, 1st Department of Dermatology Venereology, Andreas Sygros Hospital, Athens, Greece.

PMID: 34670173
DOI: 10.1016/j.mehy.2021.110703

No abstract available

Keywords: Anti-PD1/PD-L1 therapy; BP-180; Bullous pemphigoid; Immunotherapy; PD-L1; PD1.

Publication types

Letter

MeSH terms

Autoantibodies
Early Diagnosis
Humans
Immunoglobulin G
Melanoma* / diagnosis
Pemphigoid, Bullous* / diagnosis
Programmed Cell Death 1 Receptor

Substances

Autoantibodies
Immunoglobulin G
Programmed Cell Death 1 Receptor